ArticleMolecular therapy. Oncology2026

A novel combination approach targeting P300 and DNA-PK exploits epigenetic dependencies in acute myeloid leukemia.

Srinivas Vinod Saladi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.